Transplacental transfer of oseltamivir carboxylate

Journal of Maternal-Fetal and Neonatal Medicine

Volumn 25, Issue 11, 2012, Pages 2312-2315

  Nanovskaya, Tatiana N ^a   Patrikeeva, Svetlana ^a   Zhan, Ying ^a   Hankins, Gary D V ^a   Ahmed, Mahmoud S ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

H1N1 influenza virus; Oseltamivir carboxylate; Pregnancy; Tamiflu; Transplacental transfer

Indexed keywords

4 ACETAMIDO 5 AMINO 3 (1 ETHYLPROPOXY) 1 CYCLOHEXENE 1 CARBOXYLIC ACID; ISOTOPE; PHENAZONE;

ARTICLE; BLOOD PLACENTA BARRIER; CONTROLLED STUDY; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG TRANSFORMATION; DRUG TRANSPORT; DUAL PERFUSION OF PLACENTAL LOBULE; EX VIVO STUDY; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; IN VIVO STUDY; LIQUID SCINTILLATION COUNTING; MATERNAL BLOOD; OBSTETRIC PROCEDURE; PLACENTA; PLACENTA CIRCULATION; PLACENTAL TRANSFER; PRIORITY JOURNAL;

ANTIVIRAL AGENTS; BIOLOGICAL TRANSPORT; CELLS, CULTURED; DIFFUSION; FEMALE; HUMANS; MATERNAL-FETAL EXCHANGE; ORGAN CULTURE TECHNIQUES; OSELTAMIVIR; PERFUSION; PLACENTA; PREGNANCY; TERM BIRTH; TISSUE DISTRIBUTION;

EID: 84867542600     PISSN: 14767058     EISSN: 14764954     Source Type: Journal    
DOI: 10.3109/14767058.2012.693993     Document Type: Article

References (14)

1. Dutkowski R, Thakrar B, Froehlich E, Suter P, Oo C, Ward P. Safety and pharmacology of oseltamivir in clinical use. Drug Saf 2003;26:787-801. (Pubitemid 37056109)
2. He G, Massarella J, Ward P. Clinical pharmacokinetics of the prodrug oseltamivir and its active metabolite Ro 64-0802. Clin Pharmacokinet 1999;37:471-484. (Pubitemid 30032251)
3. Moscona A. Neuraminidase inhibitors for influenza. N Engl J Med 2005;353:1363-1373. (Pubitemid 41362704)
4. Center for Disease Control and Prevention. Prevention and Control of Influenza: Recommendations of the Advisory Committee on Immunization Practices. Available at: www.cdc.gov/mmwr/pdf/rr/rr55e628.pdf. Accessed June 28, 2006;55(Early Release):1-41.
5. Berveiller P, Mir O, Vinot C, Bonati C, Duchene P, Giraud C, Gil S, Treluyer JM. Transplacental transfer of oseltamivir and its metabolite using the human perfused placental cotyledon model. Am J Obstet Gynecol 2012;206:92.e1-92.e6.
6. Worley KC, Roberts SW, Bawdon RE. The metabolism and transplacental transfer of oseltamivir in the ex vivo human model. Infect Dis Obstet Gynecol 2008;2008:927574.
7. Massarella J W, He GZ, Dorr A, Nieforth K, Ward P, Brown A. The pharmacokinetics and tolerability of the oral neuraminidase inhibitor oseltamivir (Ro 64-0796/GS4104) in healthy adult and elderly volunteers. J Clin Pharmacol 2000;40:836-843.
8. Miller RK, Wier PJ, Maulik D, di Sant'Agnese PA. Human placenta in vitro: characterization during 12 h of dual perfusion. Contrib Gynecol Obstet 1985;13:77-84. (Pubitemid 15120216)
9. Nanovskaya T, Deshmukh S, Brooks M, Ahmed MS. Transplacental transfer and metabolism of buprenorphine. J Pharmacol Exp Ther 2002;300:26-33. (Pubitemid 34028504)
10. Tamiflu (oseltamivir phosphate) prescribing information. Nutley, NJ, USA: Roche Pharmaceuticals, 2008.
11. Morimoto K, Nakakariya M, Shirasaka Y, Kakinuma C, Fujita T, Tamai I, Ogihara T. Oseltamivir (Tamiflu) efflux transport at the blood-brain barrier via P-glycoprotein. Drug Metab Dispos 2008;36:6-9.
12. Hoffmann G, Funk C, Fowler S, Otteneder MB, Breidenbach A, Rayner CR, Chu T, Prinssen EP. Nonclinical pharmacokinetics of oseltamivir and oseltamivir carboxylate in the central nervous system. Antimicrob Agents Chemother 2009;53:4753-4761.
13. Vähäkangas K, Myllynen P. Drug transporters in the human blood-placental barrier. Br J Pharmacol 2009;158:665-678.
14. Ose A, Ito M, Kusuhara H, Yamatsugu K, Kanai M, Shibasaki M, Hosokawa M, et al. Limited brain distribution of [3R,4R,5S]-4-acetamido-5-amino-3-(1- ethylpropoxy)-1-cyclohexene-1-carboxylate phosphate (Ro 64-0802), a pharmacologically active form of oseltamivir, by active efflux across the blood-brain barrier mediated by organic anion transporter 3 (Oat3/Slc22a8) and multidrug resistance-associated protein 4 (Mrp4/Abcc4). Drug Metab Dispos 2009;37:315-321.